| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.05▲ | 1.06▲ | 1.06▲ | 1.10▼ | 1.35▼ |
| MA10 | 1.05▲ | 1.06▲ | 1.06▼ | 1.15▼ | 1.65▼ |
| MA20 | 1.06▲ | 1.07▼ | 1.07▼ | 1.48▼ | 1.63▼ |
| MA50 | 1.07▼ | 1.10▼ | 1.14▼ | 1.77▼ | 2.52▼ |
| MA100 | 1.08▼ | 1.16▼ | 1.32▼ | 1.66▼ | 2.86▼ |
| MA200 | 1.14▼ | 1.44▼ | 1.64▼ | 2.27▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.002▲ | 0.003▲ | -0.032▼ | -0.032▼ |
| RSI | 51.307▲ | 42.312▼ | 38.242▼ | 30.873▼ | 36.274▼ |
| STOCH | 13.333▼ | 42.500 | 28.368 | 6.943▼ | 23.474 |
| WILL %R | -20.000▲ | -33.333 | -73.333 | -98.113▼ | -99.457▼ |
| CCI | -37.037 | -103.704▼ | -84.792 | -125.454▼ | -151.936▼ |
| ▲ GAP | $SNTI Open Gap Up %2 | Set Alert |
|
Wednesday, April 16, 2025 06:15 AM
SOUTH SAN FRANCISCO, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/12/25 | 1.09 | 1.09 | 1.04 | 1.05 | 343,900 |
| 29/12/25 | 1.07 | 1.13 | 1.05 | 1.06 | 501,500 |
| 26/12/25 | 1.14 | 1.165 | 1.06 | 1.06 | 587,100 |
| 24/12/25 | 1.13 | 1.17 | 1.124 | 1.15 | 562,000 |
| 23/12/25 | 1.22 | 1.24 | 1.14 | 1.16 | 514,600 |
| 22/12/25 | 1.22 | 1.275 | 1.18 | 1.22 | 356,400 |
| 19/12/25 | 1.19 | 1.21 | 1.16 | 1.20 | 454,900 |
| 18/12/25 | 1.21 | 1.24 | 1.15 | 1.17 | 558,400 |
| 17/12/25 | 1.24 | 1.29 | 1.21 | 1.22 | 387,400 |
| 16/12/25 | 1.21 | 1.275 | 1.15 | 1.25 | 870,200 |
|
|
||||
|
|
||||
|
|